HIV-1 Tat induced microglial EVs leads to neuronal synaptodendritic injury: microglia-neuron cross-talk in NeuroHIV

Abstract

Aim: Activation of microglial NLRP3 inflammasome is an essential contributor to neuroinflammation underlying HIV-associated neurological disorders (HAND). Under pathological conditions, microglia-derived-EVs (MDEVs) can affect neuronal functions by delivering neurotoxic mediators to recipient cells. However, the role of microglial NLRP3 in mediating neuronal synaptodendritic injury has remained unexplored to date. In the present study, we sought to assess the regulatory role of HIV-1 Tat induced microglial NLRP3 in neuronal synaptodendritic injury. We hypothesized that HIV-1 Tat mediated microglia EVs carrying significant levels of NLRP3 contribute to the synaptodendritic injury, thereby affecting the maturation of neurons.

Methods: To understand the cross-talk between microglia and neuron, we isolated EVs from BV2 and human primary microglia (HPM) cells with or without NLRP3 depletion using siNLRP3 RNA. EVs were isolated by differential centrifugation, characterized by ZetaView nanoparticle tracking analysis, electron microscopy, and western blot analysis for exosome markers. Purified EVs were exposed to primary rat neurons isolated from E18 rats. Along with green fluorescent protein (GFP) plasmid transfection, immunocytochemistry was performed to visualize neuronal synaptodendritic injury. Western blotting was employed to measure siRNA transfection efficiency and the extent of neuronal synaptodegeneration. Images were captured in confocal microscopy, and subsequently, Sholl analysis was performed for analyzing dendritic spines using neuronal reconstruction software Neurolucida 360. Electrophysiology was performed on hippocampal neurons for functional assessment.

Results: Our findings demonstrated that HIV-1 Tat induced expression of microglial NLRP3 and IL1β, and further that these were packaged in microglial exosomes (MDEV) and were also taken up by the neurons. Exposure of rat primary neurons to microglial Tat-MDEVs resulted in downregulation of synaptic proteins- PSD95, synaptophysin, excitatory vGLUT1, as well as upregulation of inhibitory proteins- Gephyrin, GAD65, thereby implicating impaired neuronal transmissibility. Our findings also showed that Tat-MDEVs not only caused loss of dendritic spines but also affected numbers of spine sub-types- mushroom and stubby. Synaptodendritic injury further affected functional impairment as evidenced by the decrease in miniature excitatory postsynaptic currents (mEPSCs). To assess the regulatory role of NLRP3 in this process, neurons were also exposed to Tat-MDEVs from NLRP3 silenced microglia. Tat-MDEVs from NLRP3 silenced microglia exerted a protective role on neuronal synaptic proteins, spine density as well as mEPSCs.

Conclusion: In summary, our study underscores the role of microglial NLRP3 as an important contributor to Tat-MDEV mediated synaptodendritic injury. While the role of NLRP3 in inflammation is well-described, its role in EV-mediated neuronal damage is an interesting finding, implicating it as a target for therapeutics in HAND.

Keywords

NLRP3 / microglia-derived EVs / synaptodendritic injury / mEPSC

References

[1] Joseph SB,Sturdevant CB.HIV-1 target cells in the CNS.J Neurovirol2015;21:276-89 PMCID:PMC4366351

[2] Kranick SM.Neurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapy.Continuum (Minneap Minn)2012;18:1319-37 PMCID:PMC3760534

[3] Rojas-Celis V,Soto-Rifo R.New challenges of HIV-1 infection: how HIV-1 attacks and resides in the central nervous system.Cells2019;8:1245 PMCID:PMC6829584

[4] Kusdra L,Pulliam L.Changes in monocyte/macrophage neurotoxicity in the era of HAART: implications for HIV-associated dementia.AIDS2002;16:31-8

[5] Debaisieux S,Yezid H.The ins and outs of HIV-1 Tat.Traffic2012;13:355-63

[6] Schwarze SR,Vocero-Akbani A.In vivo protein transduction: delivery of a biologically active protein into the mouse.Science1999;285:1569-72

[7] Roy S,Chen CH,Sonenberg N.A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation.Genes Dev1990;4:1365-73

[8] Rice AP.The HIV-1 Tat protein: mechanism of action and target for HIV-1 cure strategies.Curr Pharm Des2017;23:4098-102 PMCID:PMC5700838

[9] Garden GA.Microglia in human immunodeficiency virus-associated neurodegeneration.Glia2002;40:240-51

[10] Churchill MJ,Cowley D.Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia.Ann Neurol2009;66:253-8

[11] Brack-Werner R.Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis.AIDS1999;13:1-22

[12] Sabatier JM,Mabrouk K.Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1.J Virol1991;65:961-7 PMCID:PMC239839

[13] Conant K,Atwood W,Traub R.In vivo and in vitro infection of the astrocyte by HIV-1.Advances in Neuroimmunology1994;4:287-9

[14] Tornatore C,Atwood W,Major E.Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes.J Virol1994;68:93-102 PMCID:PMC236268

[15] Liu Y,Hingtgen CM.Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands.Nat Med2000;6:1380-7

[16] King JE,Buckner CM.HIV tat and neurotoxicity.Microbes Infect2006;8:1347-57

[17] Hargus NJ.Human immunodeficiency virus-1 Tat protein increases the number of inhibitory synapses between hippocampal neurons in culture.J Neurosci2013;33:17908-20 PMCID:PMC3818559

[18] Santerre M,Gorecki L.HIV-1 Tat protein promotes neuronal dysregulation by inhibiting E2F transcription factor 3 (E2F3).J Biol Chem2019;294:3618-33 PMCID:PMC6416426

[19] Marinelli S,Marrone MC.Microglia-neuron crosstalk: signaling mechanism and control of synaptic transmission.Semin Cell Dev Biol2019;94:138-51

[20] Matejuk A.Crosstalk between astrocytes and microglia: an overview.Front Immunol2020;11:1416 PMCID:PMC7378357

[21] Potolicchio I,Xu X.Proteomic analysis of microglia-derived exosomes: metabolic role of the aminopeptidase CD13 in neuropeptide catabolism.J Immunol2005;175:2237-43

[22] Fauré J,Court M.Exosomes are released by cultured cortical neurones.Mol Cell Neurosci2006;31:642-8

[23] Upadhya R,Shetty S.Astrocyte-derived extracellular vesicles: neuroreparative properties and role in the pathogenesis of neurodegenerative disorders.J Control Release2020;323:225-39 PMCID:PMC7299747

[24] Delpech JC,Botros MB.Neuroimmune crosstalk through extracellular vesicles in health and disease.Trends Neurosci2019;42:361-72 PMCID:PMC6486849

[25] You Y.Emerging roles of extracellular vesicles in neurodegenerative disorders.Neurobiol Dis2019;130:104512 PMCID:PMC6689424

[26] Yang Y,Dunning CJR,Lambertsen KL.Inflammation leads to distinct populations of extracellular vesicles from microglia.J Neuroinflammation2018;15:168 PMCID:PMC5972400

[27] Aires ID,Boia R.Microglial extracellular vesicles as vehicles for neurodegeneration spreading.Biomolecules2021;11:770 PMCID:PMC8224033

[28] Dagur RS,Sil S.Neuronal-derived extracellular vesicles are enriched in the brain and serum of HIV-1 transgenic rats.J Extracell Vesicles2020;9:1703249 PMCID:PMC6968593

[29] Sil S,Chemparathy DT,Gordon L.Astrocytes & astrocyte derived extracellular vesicles in morphine induced amyloidopathy: implications for cognitive deficits in opiate abusers.Aging Dis2021;12:1389-408 PMCID:PMC8407877

[30] Apcher G,Zantopf D.Human immunodeficiency virus-1 Tat protein interacts with distinct proteasomal α and β subunits.FEBS Letters2003;553:200-4

[31] Sil S,Tom E,Periyasamy P.Cocaine mediated neuroinflammation: role of dysregulated autophagy in pericytes.Mol Neurobiol2019;56:3576-90 PMCID:PMC6393223

[32] McCarthy MK.The immunoproteasome and viral infection: a complex regulator of inflammation.Front Microbiol2015;6:21 PMCID:PMC4310299

[33] Thangaraj A,Liao K.HIV-1 TAT-mediated microglial activation: role of mitochondrial dysfunction and defective mitophagy.Autophagy2018;14:1596-619 PMCID:PMC6135576

[34] Minakaki G,Kittel A.Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype.Autophagy2018;14:98-119 PMCID:PMC5846507

[35] Leidal AM.Emerging roles for the autophagy machinery in extracellular vesicle biogenesis and secretion.FASEB Bioadv2021;3:377-86 PMCID:PMC8103724

[36] Chivero ET,Periyasamy P,Callen SE.HIV-1 Tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation.J Neurosci2017;37:3599-609 PMCID:PMC5373137

[37] Arikkath J,Ng YG.Delta-catenin regulates spine and synapse morphogenesis and function in hippocampal neurons during development.J Neurosci2009;29:5435-42 PMCID:PMC2763482

[38] Beaudoin GM 3rd,Singh D.Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex.Nat Protoc2012;7:1741-54

[39] Hu G,Liao K.HIV-1 Tat-induced astrocytic extracellular vesicle miR-7 impairs synaptic architecture.J Neuroimmune Pharmacol2020;15:538-53 PMCID:PMC7008083

[40] Song L,Yao S,Shang Y.NLRP3 inflammasome in neurological diseases, from functions to therapies.Front Cell Neurosci2017;11:63 PMCID:PMC5343070

[41] von Herrmann KM,Martinez EM.NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson’s disease.NPJ Parkinsons Dis2018;4:24 PMCID:PMC6093937

[42] Saylor D,Sacktor N.HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.Nat Rev Neurol2016;12:234-48 PMCID:PMC4937456

[43] Kovalevich J.Neuronal toxicity in HIV CNS disease.Future Virol2012;7:687-98 PMCID:PMC3632417

[44] Alvarez-Carbonell D,Ramanath N.Cross-talk between microglia and neurons regulates HIV latency.PLoS Pathog2019;15:e1008249 PMCID:PMC6953890

[45] Borrajo A,Penedo MA,Agís-Balboa RC.Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis.Ann Med2021;53:43-69 PMCID:PMC7877929

[46] Ru W.HIV-associated synaptic degeneration.Mol Brain2017;10:40 PMCID:PMC5576336

[47] Ru W,Bae C.Microglia mediate HIV-1 gp120-induced synaptic degeneration in spinal pain neural circuits.J Neurosci2019;39:8408-21 PMCID:PMC6794928

[48] Guo M,Feng Y.Microglial exosomes in neurodegenerative disease.Front Mol Neurosci2021;14:630808 PMCID:PMC8148341

[49] Paolicelli RC,Rajendran L.Cell-to-cell communication by extracellular vesicles: focus on microglia.Neuroscience2019;405:148-57

[50] Holm MM,Schwab ME.Extracellular vesicles: multimodal envoys in neural maintenance and repair.Trends Neurosci2018;41:360-72

[51] Schnatz A,Brahmer A.Extracellular vesicles in neural cell interaction and CNS homeostasis.FASEB Bioadv2021;3:577-92 PMCID:PMC8332475

[52] Valle L, Croul S, Morgello S, Amini S, Rappaport J, Khalili K. Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy.J Neurovirol2000;6:221-8

[53] Hudson L,Nath A.Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues.J Neurovirol2000;6:145-55

[54] Li W,Steiner J.Role of Tat protein in HIV neuropathogenesis.Neurotox Res2009;16:205-20

[55] Johnson TP,Johnson KR.Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein.Proc Natl Acad Sci U S A2013;110:13588-93 PMCID:PMC3746932

[56] Guo H,Taxman DJ,Su L.HIV-1 infection induces interleukin-1β production via TLR8 protein-dependent and NLRP3 inflammasome mechanisms in human monocytes.J Biol Chem2014;289:21716-26 PMCID:PMC4118130

[57] Hernandez JC,Urcuqui-Inchima S.HIV-1 induces the first signal to activate the NLRP3 inflammasome in monocyte-derived macrophages.Intervirology2014;57:36-42

[58] Walsh JG,Mamik MK.Rapid inflammasome activation in microglia contributes to brain disease in HIV/AIDS.Retrovirology2014;11:35 PMCID:PMC4038111

[59] Bandaru VV,Sacktor N.A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects.Neurology2013;81:1492-9 PMCID:PMC3888167

[60] He X,Zeng Z.NLRP3-dependent pyroptosis is required for HIV-1 gp120-induced neuropathology.Cell Mol Immunol2020;17:283-99 PMCID:PMC7052202

[61] Kim HJ,Thayer SA.Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death.J Neurosci2008;28:12604-13 PMCID:PMC2678679

[62] Fitting S,Bull C.Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 Tat transgenic mice.Biol Psychiatry2013;73:443-53 PMCID:PMC3570635

[63] Marks WD,Schier CJ.HIV-1 Tat causes cognitive deficits and selective loss of parvalbumin, somatostatin, and neuronal nitric oxide synthase expressing hippocampal CA1 interneuron subpopulations.J Neurovirol2016;22:747-62 PMCID:PMC5107352

[64] Roscoe RF Jr,Booze RM.HIV-1 transgenic female rat: synaptodendritic alterations of medium spiny neurons in the nucleus accumbens.J Neuroimmune Pharmacol2014;9:642-53 PMCID:PMC4440570

[65] Ellis R,Masliah E.HIV and antiretroviral therapy in the brain: neuronal injury and repair.Nat Rev Neurosci2007;8:33-44

[66] Everall IP,Marcotte TD.Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center.Brain Pathol1999;9:209-17 PMCID:PMC8098484

[67] Masliah E,Marcotte TD.Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center.Ann Neurol1997;42:963-72